NFKB1 and metabolic dysfunction-associated steatotic liver disease: Oxic lipid entities such as palmitic acid, oxLDL, and free cholesterol, which are increased in NAFLD, can activate innate immune pathways (e.g., TLR4, IL-1β, TNFα, NFκB) to drive hepatic inflammation (24).